Clinical Approach to Breast Pain
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of breast pain
Breast pain, medically termed mastalgia, is one of the most common breast-related complaints encountered in clinical practice. Up to 70% of women experience breast pain at some point during their lifetime, and it accounts for approximately 50% of all breast-related consultations. Despite its high prevalence and the significant anxiety it causes, breast pain is associated with breast cancer in fewer than 1% of cases. Nevertheless, the symptom warrants careful evaluation to exclude serious pathology and to provide appropriate reassurance and management.
Definition
Breast pain (mastalgia) refers to any discomfort, tenderness, or pain localized to the breast tissue. It may be unilateral or bilateral, focal or diffuse, and can range from mild tenderness to severe pain that interferes with daily activities, sleep, and quality of life. The term encompasses pain arising from true breast parenchyma as well as pain referred from extramammary structures.
Key Epidemiology
- Lifetime prevalence: Up to 70% of women
- Proportion of breast clinic visits: 40-50%
- Association with breast cancer: Less than 1% when pain is the only symptom
- Impact on quality of life: Approximately 10-20% report severe symptoms affecting work, sleep, or sexual activity
- Age distribution: Most common in women aged 30-50 years
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 2 weeks | Mastitis, abscess, trauma, acute cyst | Often requires urgent evaluation; infection or acute pathology more likely |
| Subacute | 2 weeks to 3 months | Resolving infection, inflammatory conditions, hormonal fluctuations | May represent evolving pathology; warrants monitoring |
| Chronic | Greater than 3 months | Cyclical mastalgia, fibrocystic changes, extramammary causes | Most common presentation; benign causes predominate |
Primary Classification: Cyclical versus Non-Cyclical
The most clinically useful classification divides breast pain into cyclical and non-cyclical types, as this distinction guides both workup and management.
Cyclical Mastalgia (Approximately 65-70%)
Definition: Breast pain that varies with the menstrual cycle, typically worsening in the luteal phase (7-14 days before menstruation) and improving with onset of menses.
Characteristics:
- Usually bilateral
- Diffuse, often affecting upper outer quadrants
- Described as heaviness, fullness, or dull aching
- May radiate to axilla or arm
- Peak incidence in 30s and 40s
- Often resolves after menopause
Non-Cyclical Mastalgia (Approximately 30-35%)
Definition: Breast pain with no relationship to the menstrual cycle, occurring at any time with variable patterns.
Characteristics:
- Usually unilateral
- Often focal and localizable
- Described as sharp, burning, or stabbing
- May be constant or intermittent
- Peak incidence in 40s and 50s
- Does not resolve with menopause
| Feature | Cyclical Mastalgia | Non-Cyclical Mastalgia |
|---|---|---|
| Frequency | 65-70% of cases | 30-35% of cases |
| Laterality | Usually bilateral | Usually unilateral |
| Location | Diffuse, upper outer quadrant | Focal, variable location |
| Character | Dull, heavy, aching | Sharp, burning, stabbing |
| Timing | Luteal phase (premenstrual) | No pattern |
| Response to menopause | Often resolves | Persists |
| Response to treatment | Better response (approximately 90%) | Variable response (approximately 50%) |
Extramammary (Chest Wall) Pain
An important third category often misclassified as breast pain. Extramammary pain originates from structures adjacent to or underlying the breast but is perceived by the patient as breast pain.
| Source | Common Conditions | Distinguishing Features |
|---|---|---|
| Musculoskeletal | Costochondritis (Tietze syndrome), muscle strain, rib fracture | Reproducible with palpation of chest wall; worse with movement or deep breathing |
| Neurological | Intercostal neuralgia, cervical radiculopathy, herpes zoster | Dermatomal distribution; burning or electric quality; may have sensory changes |
| Cardiac | Angina pectoris, pericarditis | Associated with exertion; may have cardiovascular risk factors |
| Gastrointestinal | Gastroesophageal reflux disease, esophageal spasm | Relationship to meals; burning quality; may respond to antacids |
| Pulmonary | Pleuritis, pulmonary embolism | Pleuritic quality; respiratory symptoms; dyspnea |
Classification by Character
| Pain Character | Description | Typical Associations |
|---|---|---|
| Heaviness or fullness | Sensation of breast engorgement or swelling | Cyclical mastalgia, fibrocystic changes |
| Dull aching | Constant, poorly localized discomfort | Cyclical mastalgia, large breast size (macromastia) |
| Sharp or stabbing | Sudden, well-localized, brief episodes | Cysts, focal fibrosis, extramammary causes |
| Burning | Surface or deep burning sensation | Neuropathic pain, herpes zoster, inflammatory conditions |
| Throbbing | Pulsatile, often associated with warmth | Mastitis, abscess, inflammatory breast conditions |
| Tenderness | Pain on touch or pressure | Fibrocystic changes, trauma, infection |
Key Concept: The Three Categories
Breast pain should be classified into one of three categories:
- Cyclical mastalgia (65-70%) — Hormone-related, bilateral, premenstrual
- Non-cyclical mastalgia (20-25%) — Not hormone-related, often focal
- Extramammary pain (10-15%) — Arising from chest wall or referred sources
This classification is the foundation for appropriate workup and management. Correctly identifying extramammary causes prevents unnecessary breast imaging and allows targeted treatment.
Impact on Quality of Life
| Domain Affected | Reported Impact | Prevalence |
|---|---|---|
| Sleep disturbance | Difficulty sleeping, waking due to pain | 30-40% of women with severe mastalgia |
| Physical activity | Avoidance of exercise, sports, or physical work | 25-35% |
| Sexual activity | Pain during intimacy, avoidance of touch | 20-30% |
| Work and daily activities | Reduced productivity, absenteeism | 15-20% |
| Psychological | Anxiety about breast cancer, depression | 40-50% |
Clinical Pearl: Reassurance is Therapeutic
Studies show that up to 85% of women presenting with breast pain have significant anxiety about breast cancer. In many cases, thorough evaluation followed by clear reassurance that the pain is not due to cancer provides substantial relief—even without additional treatment. Addressing this fear early in the consultation improves outcomes.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of breast pain
Understanding the pathophysiology of breast pain is essential for rational clinical decision-making. The breast is a hormonally responsive organ with complex innervation, and pain can arise through multiple mechanisms including hormonal stimulation, inflammation, structural changes, and referred pain from adjacent structures.
Breast Anatomy and Sensory Innervation
| Component | Structure | Clinical Relevance |
|---|---|---|
| Sensory innervation | Lateral and anterior cutaneous branches of intercostal nerves T2-T6 | Dermatomal distribution explains referred pain patterns; intercostal neuralgia can mimic breast pain |
| Glandular tissue | 15-20 lobes of tubuloalveolar glands arranged radially | Hormonal responsiveness leads to cyclical changes; dense tissue may be more symptomatic |
| Ductal system | Lactiferous ducts converging at nipple | Ductal ectasia and periductal inflammation cause focal pain |
| Stromal tissue | Fibrous connective tissue (Cooper’s ligaments) and adipose tissue | Fibrosis causes nodularity and focal tenderness; fat necrosis causes localized pain |
| Chest wall structures | Pectoralis muscles, ribs, costochondral junctions | Source of extramammary pain often attributed to breast |
Mechanisms of Cyclical Mastalgia
Cyclical mastalgia is linked to the hormonal fluctuations of the menstrual cycle, though the exact pathophysiology remains incompletely understood. Multiple mechanisms have been proposed:
Hormonal Sensitivity
Mechanism: Breast tissue exhibits increased sensitivity to normal circulating hormone levels rather than absolute hormone excess.
Evidence: Serum estrogen and progesterone levels are typically normal in women with cyclical mastalgia.
Clinical relevance: Explains why symptoms vary among women with similar hormone levels.
Estrogen-Progesterone Imbalance
Mechanism: Relative estrogen excess or luteal phase progesterone deficiency leads to breast tissue proliferation and edema.
Evidence: Some studies show shortened luteal phase or lower progesterone in affected women.
Clinical relevance: Basis for progesterone supplementation therapy.
Prolactin Dysregulation
Mechanism: Enhanced prolactin release or breast tissue sensitivity to prolactin causes ductal epithelial proliferation.
Evidence: Some women show exaggerated prolactin response to thyrotropin-releasing hormone stimulation.
Clinical relevance: Explains efficacy of dopamine agonists (bromocriptine) in treatment.
Fluid Retention and Edema
Mechanism: Premenstrual fluid retention causes breast tissue swelling, stretching of Cooper’s ligaments, and compression of nerve endings.
Evidence: Breast volume increases by up to 15-30% in the luteal phase.
Clinical relevance: Explains heaviness and fullness; basis for diuretic therapy and sodium restriction.
Essential Fatty Acid Deficiency
Mechanism: Abnormal fatty acid profile leads to increased sensitivity to hormones and altered prostaglandin synthesis.
Evidence: Low levels of gamma-linolenic acid found in some women with mastalgia.
Clinical relevance: Rationale for evening primrose oil supplementation.
Menstrual Cycle and Breast Changes
| Phase | Hormonal Environment | Breast Changes | Pain Pattern |
|---|---|---|---|
| Follicular phase (Days 1-14) | Rising estrogen; low progesterone | Minimal glandular activity; breast at smallest size | Typically pain-free or minimal |
| Ovulation (Day 14) | Estrogen peak; luteinizing hormone surge | Beginning of proliferative changes | Some women note onset of discomfort |
| Luteal phase (Days 15-28) | High progesterone; moderate estrogen | Ductal proliferation; alveolar development; stromal edema; increased blood flow | Progressive worsening; peak pain in late luteal phase |
| Menstruation | Rapid hormone withdrawal | Involution of glandular tissue; resolution of edema | Rapid improvement within first few days |
Mechanisms of Non-Cyclical Mastalgia
| Condition | Mechanism | Clinical Features |
|---|---|---|
| Breast cysts | Distension of blocked ducts; cyst fluid may contain inflammatory mediators; rapid enlargement causes stretching pain | Focal, often sudden onset; may fluctuate with size; well-localized |
| Fibroadenoma | Mass effect and compression of adjacent tissue; rarely painful unless infarcted or rapidly growing | Usually painless; pain suggests complication or large size |
| Ductal ectasia | Periductal inflammation and fibrosis; dilation of subareolar ducts with accumulation of secretions | Periareolar burning or itching; may have nipple discharge |
| Fat necrosis | Trauma-induced adipocyte death triggers inflammatory response and fibrosis | History of trauma or surgery; focal tenderness with palpable mass |
| Mastitis | Bacterial infection (usually Staphylococcus aureus) causes acute inflammation; may progress to abscess | Acute onset; erythema, warmth, fever; often in lactating women |
| Mondor disease | Superficial thrombophlebitis of thoracoepigastric veins; causes linear cord-like induration | Palpable tender cord; may follow trauma or surgery |
| Breast cancer | Direct invasion of nerve endings; inflammatory changes (inflammatory breast cancer); rarely presents as isolated pain | Usually associated with mass, skin changes, or nipple abnormalities; isolated pain rare (less than 1%) |
Mechanisms of Extramammary Pain
| Source | Mechanism | Key Distinguishing Feature |
|---|---|---|
| Costochondritis (Tietze syndrome) | Inflammation of costochondral or costosternal joints; exact etiology often unknown | Reproducible tenderness on palpation of costochondral junctions (especially 2nd-5th); worse with chest wall movement |
| Intercostal muscle strain | Overuse or trauma to intercostal muscles; micro-tears and inflammation | History of physical activity or strain; worse with specific movements or deep breathing |
| Intercostal neuralgia | Irritation or compression of intercostal nerves; may follow herpes zoster, surgery, or trauma | Dermatomal distribution (band-like); burning or electric quality; may have sensory changes |
| Cervical radiculopathy | Nerve root compression at C4-C7 can refer pain to chest wall and breast region | Associated neck pain; worse with neck movement; may have upper extremity symptoms |
| Fibromyalgia | Central sensitization leads to widespread pain; breast area may be affected | Diffuse pain at multiple sites; associated fatigue, sleep disturbance; tender points |
| Cardiac referred pain | Visceral afferents from heart share spinal segments (T1-T5) with breast innervation | Associated with exertion; cardiovascular risk factors; may have other anginal features |
Medication-Induced Breast Pain
| Drug Class | Examples | Mechanism |
|---|---|---|
| Hormonal therapies | Combined oral contraceptives, hormone replacement therapy | Exogenous estrogen and/or progesterone stimulates breast tissue proliferation |
| Fertility treatments | Clomiphene, gonadotropins | Ovarian stimulation leads to elevated estrogen levels |
| Antidepressants | Selective serotonin reuptake inhibitors, tricyclic antidepressants | Altered prolactin regulation; serotonin effects on mammary tissue |
| Antipsychotics | Risperidone, haloperidol | Dopamine blockade leads to hyperprolactinemia |
| Cardiovascular drugs | Spironolactone, digoxin, methyldopa | Spironolactone has anti-androgen effects; digoxin has estrogen-like activity |
| Gastrointestinal drugs | Metoclopramide, cimetidine | Metoclopramide blocks dopamine (raises prolactin); cimetidine has anti-androgen effects |
Often Overlooked Mechanism: The Chest Wall
Up to 10-15% of patients presenting with “breast pain” actually have chest wall pain (extramammary mastalgia). The key diagnostic maneuver is to have the patient lean forward while examining—this allows the breast to fall away from the chest wall. If the tender point remains on the chest wall rather than moving with the breast, the pain is extramammary. This simple test can prevent unnecessary breast imaging and direct treatment appropriately.
Why Understanding Mechanism Matters
Treatment selection is guided by the underlying mechanism:
- Cyclical mastalgia → Hormonal modulation, evening primrose oil, lifestyle modification
- Non-cyclical focal pain → Address underlying cause (aspirate cyst, treat infection)
- Extramammary pain → Local treatment (anti-inflammatory agents, physical therapy), not breast-directed therapy
- Medication-induced → Medication review and substitution
3. History Taking
A comprehensive approach to eliciting the breast pain history
Red Flags — Require Urgent Evaluation
- Palpable breast mass — Especially if hard, fixed, or irregular
- Skin changes — Peau d’orange, dimpling, ulceration, erythema
- Nipple changes — Retraction, inversion (new), bloody discharge
- Axillary lymphadenopathy — Fixed or matted nodes
- Fever with breast symptoms — Suggests mastitis or abscess
- Rapidly progressive pain — With inflammatory signs
- Unilateral focal persistent pain — Unchanging location for more than 2 months
- Pain in patient over 50 — With no clear benign explanation
Systematic History: The “BREAST” Approach
Use the mnemonic “BREAST” to ensure comprehensive history taking:
- B — Bilateral or unilateral? Location, laterality, and radiation pattern
- R — Rhythm and relationship to menses: Cyclical versus non-cyclical pattern
- E — Evolution: Onset, duration, progression, and any changes over time
- A — Associated symptoms: Mass, discharge, skin changes, systemic symptoms
- S — Severity and impact: Pain scale, effect on sleep, work, activities, and relationships
- T — Triggers and treatments: Aggravating and relieving factors, medications tried
Essential History Components
Pain Characteristics
| Aspect | Questions to Ask | Clinical Significance |
|---|---|---|
| Location | “Can you point with one finger to where it hurts most?” “Is the pain in both breasts or just one?” | Focal pain suggests cyst, fibroadenoma, or extramammary cause; diffuse bilateral suggests cyclical mastalgia |
| Character | “How would you describe the pain—sharp, dull, burning, heavy, aching?” | Heavy or aching suggests cyclical; sharp or burning suggests non-cyclical or neuropathic |
| Radiation | “Does the pain spread anywhere—to your arm, armpit, back, or chest?” | Axillary radiation common in cyclical mastalgia; chest wall radiation suggests extramammary cause |
| Timing | “Is the pain constant or does it come and go? When did it start?” | Intermittent suggests benign; constant unrelenting pain warrants closer evaluation |
| Duration | “How long have you had this pain? Days, weeks, months?” | Acute (less than 2 weeks) suggests infection or trauma; chronic suggests cyclical or structural cause |
Menstrual Relationship (Critical for Classification)
| Question | Purpose | Interpretation |
|---|---|---|
| “Does the pain change with your menstrual cycle?” | Establish cyclical versus non-cyclical pattern | Cyclical pattern strongly suggests benign hormonal etiology |
| “When in your cycle is the pain worst?” | Confirm luteal phase timing | Premenstrual worsening (7-14 days before period) is classic for cyclical mastalgia |
| “Does the pain improve when your period starts?” | Confirm hormonal relationship | Improvement with menses confirms cyclical pattern |
| “What is the date of your last menstrual period?” | Establish cycle phase; rule out pregnancy | Pregnancy causes breast tenderness; important to exclude |
| “Are your periods regular?” | Assess hormonal status | Irregular cycles may indicate hormonal imbalance |
| “Have you gone through menopause?” | Context for cyclical versus non-cyclical | Cyclical mastalgia typically resolves post-menopause; new pain in postmenopausal women needs evaluation |
Clinical Pearl: The Pain Diary
When the relationship to menses is unclear, ask the patient to keep a daily pain diary for 2-3 menstrual cycles, rating pain on a scale of 0-10 and marking menstrual days. This clearly demonstrates cyclical patterns that patients may not recognize and serves as an objective baseline for treatment response.
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Cyclical mastalgia | Bilateral, diffuse, premenstrual, upper outer quadrants | “Does the pain come in a pattern with your period, getting worse before and better after it starts?” |
| Breast cyst | Focal, sudden onset, may fluctuate, tender lump | “Did you notice a lump appear suddenly, and does the pain seem to come from that spot?” |
| Mastitis or abscess | Acute, unilateral, erythema, fever, lactating | “Are you breastfeeding? Do you have fever, redness, or warmth of the breast?” |
| Fat necrosis | History of trauma or surgery, focal, firm mass | “Have you had any injury to your breast, or any breast surgery or biopsy?” |
| Costochondritis | Worse with movement, reproducible on chest wall | “Is the pain worse when you move, breathe deeply, or press on your ribs?” |
| Cervical radiculopathy | Associated neck pain, arm symptoms | “Do you have any neck pain, or does the pain shoot down your arm?” |
| Medication-induced | Temporal relationship to medication start | “Have you started any new medications recently, including hormones, antidepressants, or blood pressure drugs?” |
| Breast cancer | Persistent focal pain, associated mass or skin changes | “Have you noticed any lumps, skin changes, nipple discharge, or changes in the shape of your breast?” |
Associated Symptoms to Elicit
Breast-Specific Symptoms
- Mass or lump: “Have you felt any lumps or thickening?”
- Nipple discharge: “Any fluid from your nipples? What color?”
- Skin changes: “Any redness, dimpling, or texture changes?”
- Nipple changes: “Has your nipple changed shape or pulled inward?”
- Swelling: “Does the breast look larger or feel swollen?”
- Warmth: “Does the breast feel warm to touch?”
Systemic and Referred Symptoms
- Fever or chills: Suggests infection
- Weight loss: Red flag for malignancy
- Neck or back pain: Suggests referred source
- Shortness of breath: Cardiac or pulmonary cause
- Skin rash: Consider herpes zoster
- Chest pain with exertion: Cardiac evaluation needed
Medication and Hormonal History
Medications That Cause Breast Pain
- Hormonal contraceptives — Combined pills, patches, rings; estrogen-related
- Hormone replacement therapy — Estrogen with or without progesterone
- Fertility medications — Clomiphene, gonadotropins
- Selective serotonin reuptake inhibitors — Fluoxetine, sertraline, paroxetine
- Antipsychotics — Risperidone, haloperidol (via hyperprolactinemia)
- Spironolactone — Anti-androgen effects
- Digoxin — Estrogen-like activity
- Metoclopramide — Raises prolactin levels
Hormonal History Questions
- Contraception: “What birth control do you use?”
- Hormone therapy: “Are you taking any hormone medications?”
- Recent changes: “Have you recently started, stopped, or changed any hormonal medications?”
- Pregnancy: “Could you be pregnant?”
- Breastfeeding: “Are you currently breastfeeding or recently stopped?”
- Menopausal status: “Have you gone through menopause? Are you having symptoms?”
Past Medical, Surgical, and Family History
| Category | Key Questions | Relevance |
|---|---|---|
| Previous breast problems | “Have you had breast pain, cysts, or lumps before? Any biopsies?” | Recurrent cysts and fibrocystic changes are common; prior biopsy may cause fat necrosis |
| Breast surgery | “Have you had any breast surgery—biopsy, reduction, augmentation, mastectomy?” | Post-surgical pain, capsular contracture (implants), fat necrosis |
| Breast cancer history | “Have you ever been diagnosed with breast cancer?” | Recurrence, treatment-related pain, heightened anxiety |
| Family history | “Does anyone in your family have breast or ovarian cancer?” | Family history increases cancer concern; may guide imaging decisions |
| Musculoskeletal conditions | “Do you have arthritis, fibromyalgia, or chronic pain conditions?” | May explain extramammary pain; fibromyalgia causes diffuse pain including breast |
| Cardiac risk factors | “Do you have high blood pressure, diabetes, high cholesterol, or heart disease?” | Chest pain in patient with cardiac risk factors needs cardiac consideration |
Social and Lifestyle History
Lifestyle Factors
- Caffeine intake: “How much coffee, tea, or caffeinated drinks do you consume?” — High caffeine may worsen mastalgia (controversial but commonly reported)
- Smoking: “Do you smoke?” — Associated with periductal mastitis
- Alcohol: “How much alcohol do you drink?” — May affect hormone levels
- Diet: “What is your typical diet like? Do you eat a lot of fatty foods?” — High-fat diet may contribute
- Exercise: “Do you exercise regularly? What type?” — May cause musculoskeletal pain; breast support important
Practical Considerations
- Bra fit: “When were you last professionally fitted for a bra? Does your bra fit well?” — Poor support causes pain, especially in large-breasted women
- Physical activity: “Does the pain occur during or after exercise?” — May need sports bra assessment
- Occupation: “What do you do for work? Does it involve repetitive arm movements?” — May cause chest wall strain
- Trauma: “Have you had any recent injury to your chest or breast?” — Fat necrosis, hematoma
- Stress: “Are you under significant stress?” — May exacerbate pain perception
Severity and Impact Assessment
Quantify the impact — This guides treatment intensity and helps monitor response:
- “On a scale of 0-10, how would you rate the pain at its worst?”
- “Does the pain wake you from sleep?”
- “Does the pain interfere with your work or daily activities?”
- “Does the pain affect your ability to exercise or be physically active?”
- “Does the pain affect intimacy or sexual activity?”
- “How worried are you that this pain might be something serious like cancer?”
4. Physical Examination
A systematic approach to examining patients with breast pain
Systematic Framework: The breast examination should be performed systematically, including inspection, palpation of the breast and axilla, and specific maneuvers to differentiate breast from chest wall pain. Examination should always include both breasts for comparison, even when symptoms are unilateral.
General Inspection
- General appearance: Assess for signs of distress, fever, or systemic illness
- Body habitus: Note obesity (associated with macromastia-related pain) and breast size asymmetry
- Posture: Poor posture may contribute to chest wall strain and breast pain
- Skin: Look for vesicular rash (herpes zoster), generalized skin changes
- Breathing pattern: Splinting or guarding may suggest chest wall pathology
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C or 100.4°F) | Suggests mastitis, abscess, or systemic infection |
| Heart Rate | Tachycardia | May indicate infection, pain severity, or anxiety; consider cardiac causes if associated with chest pain |
| Blood Pressure | Hypertension or hypotension | Relevant for cardiac risk assessment if chest pain is a concern |
| Respiratory Rate | Tachypnea | May suggest pulmonary embolism, pneumonia, or anxiety |
| Oxygen Saturation | Hypoxia (less than 95%) | Indicates cardiopulmonary pathology requiring urgent evaluation |
Breast Inspection
Inspect with patient sitting upright, arms at sides, then arms raised overhead, then hands pressing on hips (to contract pectoralis muscles).
| Finding | Description | Clinical Significance |
|---|---|---|
| Asymmetry | Difference in size, shape, or contour between breasts | Mild asymmetry is normal; new or marked asymmetry warrants investigation |
| Skin erythema | Redness of overlying skin | Mastitis, abscess, inflammatory breast cancer; note distribution |
| Peau d’orange | Orange-peel appearance due to skin edema and tethering | Red flag — suggests inflammatory breast cancer or advanced malignancy |
| Skin dimpling or retraction | Pulling in of skin, especially with arm movement | Suggests underlying mass tethered to Cooper’s ligaments — concerning for malignancy |
| Visible mass | Obvious bulge or distortion of breast contour | Large cyst, fibroadenoma, or malignancy |
| Nipple changes | Inversion, retraction, deviation, eczematous changes | New nipple inversion is red flag; eczema may indicate Paget disease |
| Nipple discharge | Spontaneous discharge visible on inspection | Bloody or clear unilateral discharge warrants investigation |
| Visible veins | Prominent superficial venous pattern | Normal in pregnancy and lactation; unilateral prominence may indicate underlying mass |
| Scars | Evidence of prior surgery or biopsy | May explain focal pain; documents surgical history |
Breast Palpation
Examine with patient supine, arm raised behind head on the side being examined. Use the flat pads of the three middle fingers in small circular motions, covering the entire breast systematically (vertical strip or concentric circle pattern).
What to Assess on Palpation
Breast Tissue Assessment
- Texture: Nodular, smooth, or irregular
- Tenderness: Focal versus diffuse; reproducible location
- Temperature: Warmth suggests inflammation
- Masses: Size, shape, borders, mobility, consistency
If Mass Present — Characterize
- Size: Measure in centimeters
- Location: Clock position and distance from nipple
- Shape: Round, oval, irregular
- Borders: Well-defined versus ill-defined
- Consistency: Soft, firm, hard, rubbery
- Mobility: Mobile versus fixed to skin or chest wall
- Tenderness: Painful or non-tender
| Mass Characteristic | Likely Benign | Concerning for Malignancy |
|---|---|---|
| Borders | Smooth, well-defined | Irregular, ill-defined |
| Consistency | Soft or rubbery | Hard, rock-like |
| Mobility | Mobile, slides easily | Fixed to skin or chest wall |
| Tenderness | Often tender (cysts) | Usually non-tender |
| Skin changes | None | Dimpling, retraction, peau d’orange |
Nipple Examination
- Inspect: Shape, symmetry, skin changes, scaling (Paget disease)
- Palpate: Gently compress nipple to assess for discharge
- Characterize discharge if present:
- Color: Milky, green, yellow, clear, bloody
- Unilateral versus bilateral: Unilateral is more concerning
- Single duct versus multiple ducts: Single duct warrants more concern
- Spontaneous versus expressed: Spontaneous is more significant
Axillary and Regional Lymph Node Examination
Support the patient’s arm and palpate the axilla systematically, including anterior (pectoral), posterior (subscapular), lateral, and apical (infraclavicular) groups.
| Finding | Description | Clinical Significance |
|---|---|---|
| No palpable nodes | Normal finding | Reassuring; does not exclude early malignancy |
| Small, soft, mobile nodes | Less than 1 cm, rubbery, non-tender | Usually reactive; common benign finding |
| Tender lymphadenopathy | Painful nodes, may be enlarged | Suggests infection or inflammation (mastitis, recent vaccination) |
| Hard, fixed, matted nodes | Firm, immobile, may be clustered together | Red flag — concerning for metastatic breast cancer |
Critical Maneuver: Chest Wall Assessment
The “Lean Forward” Test — Distinguishing Breast from Chest Wall Pain
This is the most important maneuver for identifying extramammary pain:
- With patient sitting, identify the point of maximum tenderness
- Ask the patient to lean forward, allowing the breast to fall away from the chest wall
- Palpate the same area again
Interpretation:
- If tenderness remains on the chest wall → Extramammary (chest wall) pain
- If tenderness moves with the breast → True breast pain
Chest Wall Examination
| Structure | How to Examine | Positive Findings |
|---|---|---|
| Costochondral junctions | Palpate along the sternal border at rib attachments (especially 2nd-5th) | Point tenderness suggests costochondritis (Tietze syndrome) |
| Ribs | Palpate along the rib cage for focal tenderness | Focal tenderness may indicate rib contusion, fracture, or muscle attachment strain |
| Intercostal spaces | Palpate between ribs for muscle tenderness | Tenderness suggests intercostal muscle strain or neuralgia |
| Pectoralis muscles | Palpate with muscle contracted (hands pressing against hips) | Tenderness suggests pectoralis strain |
| Lateral chest wall | Palpate serratus anterior along the lateral ribs | Tenderness with overhead activities suggests serratus strain |
Additional Relevant Examinations
Cervical Spine
- Range of motion — pain or limitation
- Spurling test — reproduction of radicular symptoms with neck extension and rotation
- Tenderness over cervical paraspinal muscles
Shoulder
- Range of motion — may reveal rotator cuff pathology
- Referred shoulder pain can manifest as breast or chest pain
Cardiovascular (if indicated)
- Heart sounds — murmurs, gallops, pericardial rub
- Jugular venous pressure — elevated in heart failure
- Lower extremity edema
Expected Findings by Etiology
| Condition | Inspection | Palpation | Other Findings |
|---|---|---|---|
| Cyclical mastalgia | Usually normal; may note fullness | Diffuse nodularity; bilateral upper outer quadrant tenderness | Normal axillary nodes; varies with cycle |
| Non-cyclical mastalgia | Usually normal | Focal tenderness; may have underlying nodule | No cyclical variation |
| Breast cyst | May see visible mass if large | Smooth, round, mobile mass; tender; may feel tense | Size may fluctuate |
| Fibroadenoma | Usually normal | Firm, rubbery, mobile (“breast mouse”); usually non-tender | Does not change with cycle |
| Mastitis | Erythema, swelling; may see skin breakdown | Warm, tender, indurated area; may have fluctuance (abscess) | Fever; tender axillary nodes; lactating |
| Costochondritis | Normal breast inspection | Breast tissue non-tender; chest wall point tenderness | Pain reproduced with chest wall pressure; positive lean forward test |
| Breast cancer | May have skin changes, nipple retraction, asymmetry | Hard, irregular, fixed mass; usually non-tender | May have axillary lymphadenopathy |
Important Teaching Point
Normal examination is common! The majority of women presenting with breast pain — including those with cyclical mastalgia, non-cyclical mastalgia, and many with medication-induced breast pain — will have a completely normal physical examination. A normal examination does not exclude significant pathology, but in the context of typical cyclical symptoms and no red flags, it is highly reassuring. The examination’s primary purpose is to identify concerning features that warrant imaging, not to diagnose the cause of benign mastalgia.
Documentation Essentials
Document the following for every breast examination:
- Inspection findings (or “no skin changes, nipple abnormality, or asymmetry”)
- Palpation findings — texture, masses (with full characterization), tenderness location
- Axillary lymph node status
- Chest wall examination findings (especially if pain is present)
- Result of “lean forward” maneuver if performed
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The differential diagnosis of breast pain is broad, but the vast majority of cases are due to benign causes. The key clinical task is to systematically categorize the pain as cyclical, non-cyclical, or extramammary, then consider etiologies within that category while remaining vigilant for red flags suggesting serious pathology.
Step-by-Step Approach to Breast Pain:
- Step 1: Rule out red flags — Is there a mass, skin changes, nipple abnormality, or signs of infection?
- Step 2: Classify the pain — Cyclical, non-cyclical, or extramammary?
- Step 3: Consider causes within that category based on clinical features
- Step 4: Review medications — Could this be drug-induced?
- Step 5: Consider age and risk factors — Does this patient need imaging?
Cyclical Mastalgia (65-70% of Breast Pain)
| Probability | Condition | Key Features | Notes |
|---|---|---|---|
| VERY COMMON (>90%) | Physiological cyclical mastalgia | Bilateral, diffuse, upper outer quadrants; premenstrual worsening; improves with menses | Normal hormonal response; no specific pathology identified |
| COMMON | Fibrocystic changes | Nodular breast tissue; bilateral; cyclical tenderness; may have palpable lumps | Previously called “fibrocystic disease” — now considered normal variant |
| LESS COMMON | Hormonal contraceptive-related | Onset correlates with starting or changing hormonal contraception | Often improves after 2-3 months; may need formulation change |
| LESS COMMON | Perimenopause-related | Irregular cycles; age 40-55; fluctuating symptoms | Hormonal instability causes variable breast symptoms |
Non-Cyclical Mastalgia (20-25% of Breast Pain)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 40%) | Breast cyst | Focal, sudden onset; palpable smooth mass; may fluctuate in size | Bloody aspirate; solid component on ultrasound |
| COMMON (approximately 20%) | Focal fibrosis or stromal fibrosis | Focal area of firmness and tenderness; no discrete mass | None if imaging benign |
| LESS COMMON (approximately 15%) | Ductal ectasia | Periareolar burning or itching; may have nipple discharge (often green or brown); subareolar mass | Bloody discharge; associated mass |
| LESS COMMON (approximately 10%) | Fat necrosis | History of trauma or surgery; focal firm mass; may have skin tethering | Can mimic cancer on examination and imaging |
| LESS COMMON | Fibroadenoma (when symptomatic) | Firm, rubbery, mobile mass; usually painless but can cause discomfort if large | Rapid growth; size greater than 3 cm |
| LESS COMMON | Mondor disease (superficial thrombophlebitis) | Palpable tender cord; linear induration on breast surface | May occur after surgery or trauma; rarely associated with underlying malignancy |
| UNCOMMON (<5%) | Mastitis (non-lactational) | Periareolar; often in smokers; may form abscess; recurrent | Fever; abscess formation; failure to respond to antibiotics |
| UNCOMMON (<1%) | Breast cancer | Usually painless; pain as only symptom is rare; may have associated mass or skin changes | Mass, skin changes, nipple abnormalities, axillary lymphadenopathy |
Extramammary (Chest Wall) Pain (10-15% of Breast Pain)
| Probability | Condition | Key Features | Distinguishing Test |
|---|---|---|---|
| COMMON (approximately 50%) | Costochondritis (Tietze syndrome) | Point tenderness at costochondral junctions (2nd-5th ribs); worse with movement or deep breathing | Reproducible on palpation of chest wall; positive lean forward test |
| COMMON (approximately 25%) | Musculoskeletal strain | History of physical activity, heavy lifting, or repetitive motion; muscular tenderness | Worse with specific movements; tender muscles on palpation |
| LESS COMMON (approximately 10%) | Intercostal neuralgia | Dermatomal distribution (band-like); burning or electric quality; may have sensory changes | Follows intercostal nerve distribution; may have preceding herpes zoster |
| LESS COMMON | Cervical radiculopathy | Associated neck pain; radiates to shoulder, arm, or chest; numbness or tingling | Positive Spurling test; neck movement reproduces symptoms |
| LESS COMMON | Fibromyalgia | Widespread pain at multiple sites; fatigue; sleep disturbance; tender points | Meets fibromyalgia diagnostic criteria; other tender points present |
| UNCOMMON BUT SERIOUS | Herpes zoster (shingles) | Unilateral; dermatomal; burning pain may precede rash by days | Vesicular rash in dermatomal distribution; history of chickenpox |
| UNCOMMON BUT SERIOUS | Cardiac disease (angina, pericarditis) | Exertional; associated with dyspnea, diaphoresis; cardiovascular risk factors | ECG changes; cardiac biomarkers; stress testing |
| UNCOMMON BUT SERIOUS | Pulmonary embolism | Pleuritic chest pain; dyspnea; tachycardia; risk factors for venous thromboembolism | D-dimer; CT pulmonary angiography |
Anatomical Approach to Breast Pain
Breast Parenchyma
Cyclical mastalgia
Fibrocystic changes
Breast cysts
Fibroadenoma
Fat necrosis
Breast cancer
Ductal System
Ductal ectasia
Periductal mastitis
Intraductal papilloma
Lactational mastitis
Breast abscess
Chest Wall
Costochondritis
Intercostal muscle strain
Rib fracture or contusion
Intercostal neuralgia
Herpes zoster
Slipping rib syndrome
Referred Sources
Cervical radiculopathy
Thoracic outlet syndrome
Cardiac disease
Gastroesophageal reflux disease
Pulmonary embolism
Shoulder pathology
Special Populations
Lactating Women
| Condition | Key Features | Urgency |
|---|---|---|
| Engorgement | Bilateral; diffuse fullness and discomfort; early postpartum or with missed feedings | Routine — supportive care |
| Blocked duct | Focal tender lump; no fever; often resolves with continued breastfeeding | Routine — may progress to mastitis if untreated |
| Lactational mastitis | Unilateral; wedge-shaped erythema; fever; flu-like symptoms | Urgent — antibiotics needed; continue breastfeeding |
| Breast abscess | Fluctuant mass; severe pain; fever; failure to improve with antibiotics | Urgent — requires drainage |
| Nipple pain (thrush, trauma) | Nipple soreness, cracking, or burning; may see white patches | Routine — assess latch; treat infection if present |
Postmenopausal Women
Important Consideration
New breast pain in postmenopausal women is less common than in premenopausal women and warrants careful evaluation. While still usually benign, the absence of cyclical hormonal influence means other causes should be considered. Pain as the sole presenting symptom of breast cancer remains rare (less than 1%), but clinical vigilance is appropriate.
Consider: Hormone replacement therapy-related pain, musculoskeletal causes, and ensure appropriate imaging based on clinical findings.
Drug-Induced Breast Pain
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Combined oral contraceptives | Estrogen stimulation of breast tissue | Often improves after 2-3 cycles; bilateral | 1-3 months |
| Hormone replacement therapy | Estrogen and/or progesterone stimulation | Common in first 3-6 months; may persist | 1-3 months |
| Selective serotonin reuptake inhibitors | Altered prolactin regulation; serotonin effects | May cause breast enlargement and tenderness | 2-4 weeks |
| Antipsychotics (risperidone, haloperidol) | Dopamine blockade causing hyperprolactinemia | Bilateral; may have galactorrhea | Variable; weeks to months |
| Spironolactone | Anti-androgen effects; estrogen-like activity | Gynecomastia in men; breast tenderness in women | 1-3 months |
| Digoxin | Estrogen-like effects on breast tissue | May cause gynecomastia and breast tenderness | Weeks to months |
| Metoclopramide | Dopamine antagonist raising prolactin | Breast tenderness; possible galactorrhea | 1-2 weeks |
| Fertility medications (clomiphene, gonadotropins) | Ovarian stimulation with elevated estrogen | Bilateral breast tenderness during treatment cycles | After treatment cycle completes |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Bilateral, diffuse, premenstrual worsening | Cyclical mastalgia | Reassurance; pain diary; consider lifestyle modifications |
| Focal pain with palpable smooth lump | Breast cyst | Ultrasound; aspiration if symptomatic |
| Periareolar burning with nipple discharge | Ductal ectasia | Ultrasound; mammography if age-appropriate |
| Unilateral pain with erythema, warmth, fever | Mastitis or abscess | Antibiotics; ultrasound if fluctuant or not improving |
| Pain reproducible by pressing on ribs | Costochondritis | NSAIDs; reassurance; no breast imaging needed |
| Band-like burning pain, dermatomal | Intercostal neuralgia or herpes zoster | Examine for rash; neuropathic pain management |
| Focal pain after trauma or surgery | Fat necrosis | Imaging to confirm; may mimic cancer |
| New pain after starting hormones | Medication-induced | Observation for 2-3 months; consider formulation change |
| Pain with hard, fixed, irregular mass | Breast cancer | Urgent imaging and biopsy |
| Exertional chest/breast pain with risk factors | Cardiac disease | ECG; cardiac workup; cardiology referral |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The approach to investigating breast pain should be guided by clinical findings, patient age, and risk factors. Many women with typical cyclical mastalgia and a normal clinical examination require no imaging. The primary role of investigations is to exclude malignancy and identify treatable causes, not to diagnose the specific cause of benign mastalgia.
Key Principles of Investigation:
- Clinical assessment first: History and examination guide imaging decisions
- Imaging is not always needed: Typical cyclical mastalgia with normal examination in low-risk patients may not require imaging
- Age-appropriate imaging: Ultrasound preferred in women under 30; mammography for women over 40
- Red flags mandate imaging: Palpable mass, skin changes, nipple abnormalities require investigation regardless of pain pattern
- Reassurance is therapeutic: Normal imaging provides significant psychological benefit
Who Needs Breast Imaging?
| Clinical Scenario | Imaging Recommended? | Preferred Modality |
|---|---|---|
| Typical cyclical mastalgia, normal examination, age under 40, no risk factors | No — reassurance appropriate | None initially; imaging if symptoms persist or worsen despite treatment |
| Typical cyclical mastalgia, normal examination, age 40 or older | Consider — especially if not up to date on screening | Mammography ± ultrasound |
| Non-cyclical focal pain, no palpable mass | Yes | Ultrasound (all ages); add mammography if age 30 or older |
| Palpable mass or thickening | Yes — mandatory | Ultrasound (under 30); mammography + ultrasound (30 or older) |
| Skin changes (dimpling, peau d’orange, erythema) | Yes — urgent | Mammography + ultrasound; consider MRI if inflammatory breast cancer suspected |
| Nipple changes (retraction, discharge) | Yes | Mammography + ultrasound; ductography if single-duct discharge |
| Chest wall pain (extramammary) | No — breast imaging not indicated | None for breast; chest radiograph or other if indicated for chest wall |
| High-risk patient (BRCA carrier, strong family history) | Yes — lower threshold for imaging | According to high-risk screening protocol; may include MRI |
Imaging Modalities
Mammography
Indications
- Age 30 or older with breast symptoms warranting imaging
- Screening in average-risk women age 40 or older
- Evaluation of palpable mass in women over 30
- Nipple discharge evaluation
Limitations
- Less sensitive in dense breast tissue (common in younger women)
- Cannot differentiate solid from cystic lesions
- Radiation exposure (low but present)
- May cause discomfort during compression
Breast Ultrasound
Indications
- First-line imaging for women under 30
- Evaluation of palpable mass at any age
- Characterization of mammographic finding (solid versus cystic)
- Guidance for aspiration or biopsy
- Evaluation of focal non-cyclical pain
- Pregnant or lactating women
Advantages
- No radiation exposure
- Excellent for cyst characterization
- Real-time imaging
- Good in dense breast tissue
- Can guide interventional procedures
Breast MRI
| Indications | Not Routinely Indicated |
|---|---|
|
|
Interpretation of Common Imaging Findings
| Finding | Description | Clinical Significance | Next Step |
|---|---|---|---|
| Simple cyst | Anechoic, well-circumscribed, posterior acoustic enhancement | Benign — no malignant potential | Aspiration only if symptomatic; otherwise reassurance |
| Complicated cyst | Internal echoes, septations, or debris | Usually benign; small risk of associated malignancy | Short-interval follow-up or aspiration |
| Solid mass — benign features | Oval, well-circumscribed, parallel orientation | Likely fibroadenoma or other benign lesion | Biopsy or short-interval follow-up depending on BI-RADS category |
| Solid mass — suspicious features | Irregular shape, spiculated margins, non-parallel orientation | Concerning for malignancy | Biopsy required |
| Fibrocystic changes | Scattered cysts, dense tissue, nodularity | Normal variant — no increased cancer risk | Reassurance; routine screening |
| Fat necrosis | Oil cyst, calcifications, or mass with fatty center | Benign — often post-traumatic | Reassurance if characteristic; biopsy if atypical features |
BI-RADS Classification and Management
| BI-RADS Category | Assessment | Likelihood of Cancer | Recommended Action |
|---|---|---|---|
| 0 | Incomplete — need additional imaging | N/A | Additional views, ultrasound, or prior films needed |
| 1 | Negative — normal | Essentially 0% | Routine screening |
| 2 | Benign finding | Essentially 0% | Routine screening |
| 3 | Probably benign | Less than or equal to 2% | Short-interval follow-up (usually 6 months) |
| 4 | Suspicious abnormality | 2-95% (subdivided 4A, 4B, 4C) | Tissue diagnosis (biopsy) recommended |
| 5 | Highly suggestive of malignancy | Greater than 95% | Biopsy required; appropriate action should be taken |
| 6 | Known biopsy-proven malignancy | 100% | Surgical excision when appropriate |
Laboratory Investigations
Laboratory Tests Are Rarely Needed
Routine blood tests are not indicated for the evaluation of breast pain. Consider the following only in specific clinical scenarios:
| Test | When to Order | What It Helps Identify |
|---|---|---|
| Pregnancy test (urine or serum beta-hCG) | Reproductive-age woman with new breast symptoms | Pregnancy as cause of breast tenderness; important before imaging |
| Prolactin level | Galactorrhea; suspected medication-induced symptoms; bilateral breast symptoms with possible hyperprolactinemia | Hyperprolactinemia (drug-induced or pituitary adenoma) |
| Thyroid function tests (TSH) | Associated symptoms of thyroid dysfunction; galactorrhea | Hypothyroidism can cause hyperprolactinemia and breast symptoms |
| Complete blood count, inflammatory markers | Suspected infection (mastitis, abscess); systemic symptoms | Leukocytosis, elevated C-reactive protein in infection |
| Cardiac biomarkers (troponin) | Chest pain with cardiac features or risk factors | Acute coronary syndrome |
| D-dimer | Suspected pulmonary embolism | Venous thromboembolism (if clinical probability warrants) |
Targeted Investigations by Suspected Etiology
If Suspecting Breast Cyst
First-Line
- Breast ultrasound: Confirms cyst; differentiates simple from complex
- Aspiration: Diagnostic and therapeutic; send fluid for cytology if bloody
Second-Line
- Mammography: If age 30 or older and not recently performed
- Core biopsy: If complex cyst or solid component identified
If Suspecting Mastitis or Abscess
First-Line
- Clinical diagnosis: Often sufficient for mastitis
- Ultrasound: If abscess suspected (fluctuance, failure to respond to antibiotics)
Second-Line
- Aspiration or drainage: If abscess confirmed; send for culture
- Mammography: After infection resolves in non-lactating women to exclude underlying malignancy
If Suspecting Extramammary (Chest Wall) Pain
First-Line
- Clinical examination: Usually diagnostic (reproducible chest wall tenderness)
- No breast imaging needed if clearly extramammary
Consider If Indicated
- Chest radiograph: If rib pathology or pulmonary cause suspected
- ECG: If cardiac symptoms or risk factors
- Cervical spine imaging: If radiculopathy suspected
Empiric Treatment Trials as Diagnostic Tools
Treatment Response Can Support Diagnosis
In selected cases, response to empiric therapy can help confirm the suspected diagnosis. This approach is most useful when clinical features are typical and imaging is reassuring.
- Lifestyle modifications and supportive measures: If cyclical mastalgia suspected — improvement supports diagnosis
- Evening primrose oil trial: 3-month trial for cyclical mastalgia; response suggests hormonal/nutritional etiology
- NSAIDs (topical or oral): If costochondritis or musculoskeletal pain suspected — rapid response confirms
- Medication discontinuation: If drug-induced pain suspected — resolution after stopping confirms
- Antibiotics: If mastitis suspected — clinical improvement within 48-72 hours
When Is Biopsy Indicated?
| Indication | Type of Biopsy | Notes |
|---|---|---|
| BI-RADS 4 or 5 lesion | Core needle biopsy (ultrasound or stereotactic-guided) | Standard approach for suspicious imaging findings |
| Palpable mass with suspicious features | Core needle biopsy or fine needle aspiration | Even if imaging appears benign, clinical suspicion warrants tissue diagnosis |
| Bloody nipple discharge | Duct excision or core biopsy of associated lesion | To exclude intraductal papilloma or carcinoma |
| Skin changes (peau d’orange, ulceration) | Skin punch biopsy or core biopsy | To evaluate for inflammatory breast cancer or Paget disease |
| Nipple eczema not responding to treatment | Nipple biopsy | To exclude Paget disease of the nipple |
Clinical Pearl: The Value of Reassurance
For many women with breast pain, the most valuable investigation is the one that provides reassurance. Studies show that up to 85% of women presenting with breast pain have significant anxiety about breast cancer. When clinical evaluation and appropriate imaging are normal, taking time to explain the benign nature of the condition and providing clear reassurance can be more therapeutic than any medication.
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Breast pain with hard, fixed mass, skin changes, or bloody nipple discharge | EMERGENT | Urgent imaging (mammogram + ultrasound); expedited referral to breast surgery; biopsy within 1-2 weeks |
| Suspected inflammatory breast cancer (diffuse erythema, peau d’orange, rapid onset) | EMERGENT | Urgent mammography + ultrasound; skin punch biopsy; immediate oncology/breast surgery referral |
| Breast pain with fever, erythema, and fluctuance (abscess) | URGENT | Ultrasound to confirm; aspiration or incision and drainage; antibiotics; follow-up within 48-72 hours |
| Mastitis (erythema, warmth, fever without fluctuance) | URGENT | Start antibiotics; continue breastfeeding if lactating; reassess in 48-72 hours |
| Chest/breast pain with exertional component and cardiac risk factors | URGENT | ECG; cardiac evaluation; may need stress testing or cardiology referral |
| Non-cyclical focal pain without mass, normal examination | ROUTINE | Imaging based on age and risk; follow-up in 4-6 weeks |
| Typical cyclical mastalgia, normal examination | ROUTINE | Reassurance; lifestyle modifications; imaging optional based on age/risk; follow-up as needed |
Step 2: Classify the Pain
Cyclical
Features: Bilateral, diffuse, premenstrual worsening, improves with menses
Action: Proceed to Algorithm A
Non-Cyclical
Features: Unilateral, focal, no menstrual relationship, constant or intermittent
Action: Proceed to Algorithm B
Extramammary
Features: Reproducible on chest wall, positive lean-forward test, dermatomal distribution
Action: Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Cyclical Mastalgia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Bilateral, premenstrual, normal examination, age under 40 | Physiological cyclical mastalgia | Reassurance; lifestyle modifications (supportive bra, reduce caffeine); pain diary; follow-up in 2-3 months |
| Bilateral, premenstrual, normal examination, age 40 or older | Cyclical mastalgia | Reassurance; ensure up to date on mammographic screening; lifestyle modifications; follow-up |
| Cyclical pattern but with palpable mass | Cyclical mastalgia with incidental finding | Imaging to evaluate mass; manage mass separately; address cyclical symptoms |
| Cyclical pain onset after starting hormonal medication | Medication-induced mastalgia | Reassure that often improves after 2-3 months; consider dose adjustment or formulation change if persistent |
| Severe cyclical pain affecting quality of life, failed conservative measures | Refractory cyclical mastalgia | Consider evening primrose oil trial; referral to breast clinic; second-line pharmacotherapy if needed |
Algorithm B: Non-Cyclical Mastalgia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Focal pain with smooth, mobile, tender lump | Breast cyst | Ultrasound to confirm; aspiration if symptomatic; reassurance if simple cyst |
| Focal pain, no palpable mass, normal examination | Focal fibrosis or stromal pain | Ultrasound (add mammography if age 30 or older); reassurance if benign imaging; NSAIDs; follow-up |
| Periareolar burning or itching with nipple discharge | Ductal ectasia | Ultrasound + mammography; duct excision if symptomatic or bloody discharge |
| Focal pain following trauma or surgery | Fat necrosis | Imaging to characterize; may mimic cancer; biopsy if imaging indeterminate |
| Unilateral pain with erythema, warmth, fever | Mastitis or abscess | Antibiotics; ultrasound if fluctuant or not improving; drainage if abscess |
| Tender linear cord on breast surface | Mondor disease | NSAIDs; warm compresses; self-limiting; imaging if associated mass |
| Focal persistent pain with hard, fixed, or irregular mass | Possible malignancy | Urgent imaging; core biopsy; breast surgery referral |
Algorithm C: Extramammary (Chest Wall) Pain
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Point tenderness at costochondral junction, worse with movement | Costochondritis | NSAIDs (topical or oral); reassurance; no breast imaging needed; physical therapy if refractory |
| Muscle tenderness after physical activity or strain | Musculoskeletal strain | Rest; NSAIDs; stretching; activity modification |
| Band-like burning pain, dermatomal distribution | Intercostal neuralgia | Neuropathic pain agents (gabapentin, amitriptyline); intercostal nerve block if refractory |
| Dermatomal pain with vesicular rash | Herpes zoster | Antivirals within 72 hours of rash onset; pain management; post-herpetic neuralgia prevention |
| Pain with neck movement, arm symptoms | Cervical radiculopathy | Cervical spine imaging; physical therapy; pain management; neurosurgery if severe |
| Exertional pain with cardiac risk factors | Cardiac disease | ECG; troponin if acute; stress testing; cardiology referral |
Step 4: Age-Based Imaging Decisions
| Age Group | Clinical Situation | Recommended Imaging |
|---|---|---|
| Under 30 years | Palpable mass or focal symptoms | Ultrasound first; mammography only if ultrasound suspicious |
| Under 30 years | Typical cyclical mastalgia, normal examination | No imaging required; clinical follow-up |
| 30-39 years | Focal symptoms or palpable finding | Ultrasound ± mammography |
| 30-39 years | Typical cyclical mastalgia, normal examination | Consider ultrasound for reassurance; mammography not routine |
| 40 years and older | Any breast symptom requiring evaluation | Mammography + ultrasound |
| 40 years and older | Typical cyclical mastalgia, normal examination | Ensure up to date on screening mammography; additional imaging optional |
| Any age with high-risk factors | BRCA carrier, strong family history, prior chest radiation | Lower threshold for imaging; follow high-risk screening protocols |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient is very anxious about cancer despite reassurance | Acknowledge concerns; explain low risk of cancer with pain alone | Offer imaging for reassurance if clinically appropriate; schedule follow-up |
| Imaging shows BI-RADS 3 (probably benign) | Explain that findings are likely benign but need monitoring | Short-interval follow-up imaging at 6 months; if stable at 2 years, return to routine screening |
| Imaging shows BI-RADS 4 or 5 (suspicious) | Explain need for tissue diagnosis; provide support | Arrange core biopsy; expedited breast surgery referral |
| Patient refuses imaging despite clinical indication | Document discussion of risks and recommendations | Offer close clinical follow-up; revisit imaging discussion at follow-up |
| Cyst aspirated but recurs | Re-aspirate if symptomatic | If recurs multiple times, consider surgical excision; ensure aspirate was non-bloody |
| Mastitis not improving after 48-72 hours of antibiotics | Reassess; obtain ultrasound | If abscess, arrange drainage; consider resistant organism or need for broader coverage |
| Pain persists despite normal workup and conservative treatment | Re-evaluate classification; ensure extramammary causes excluded | Consider breast clinic referral; second-line treatments; multidisciplinary pain approach |
| Patient on hormone therapy with new breast pain | Review timing of symptom onset relative to medication start | If recent start, observe for 2-3 months; if persistent, consider dose adjustment or discontinuation |
Troubleshooting Refractory Breast Pain
Ask These Questions When Pain Does Not Improve
- Is the classification correct? Re-evaluate whether pain is truly cyclical, non-cyclical, or extramammary
- Was extramammary pain adequately excluded? Repeat chest wall examination; consider cervical spine evaluation
- Was treatment duration adequate? Evening primrose oil requires 3-4 months; hormonal treatments need 2-3 cycles
- Was patient compliance good? Verify adherence to lifestyle modifications and medications
- Were medications reviewed? Ensure no new drugs were started that could cause breast pain
- Are there multiple overlapping causes? Some patients have both cyclical mastalgia and chest wall pain
- Is there a psychological component? Anxiety and depression can amplify pain perception
- Does patient need specialist referral? Consider breast clinic, pain management, or mental health support
When to Refer to Breast Specialist
| Indication | Urgency | Reason |
|---|---|---|
| Suspicious imaging (BI-RADS 4 or 5) | Urgent (within 2 weeks) | Biopsy and management of potential malignancy |
| Palpable mass not explained by imaging | Urgent (within 2 weeks) | Clinical-imaging discordance requires specialist evaluation |
| Bloody nipple discharge | Soon (within 4 weeks) | May need ductoscopy or duct excision |
| Recurrent breast abscess | Soon (within 4 weeks) | May need surgical management; exclude underlying pathology |
| Refractory mastalgia failing conservative treatment | Routine | Consider second-line therapies; specialist reassurance |
| Patient request for specialist opinion | Routine | Specialist reassurance may provide significant psychological benefit |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Pain rarely equals cancer: Breast pain as the sole presenting symptom of breast cancer is rare (less than 1%). The absence of a mass, skin changes, or nipple abnormalities in a patient with isolated breast pain is highly reassuring.
The lean-forward test is essential: This simple maneuver distinguishes breast pain from chest wall pain. If the tender point stays on the chest wall when the breast falls forward, treat the chest wall — not the breast.
Reassurance is therapeutic: Up to 85% of women with breast pain fear cancer. For many, a thorough evaluation followed by clear reassurance provides more relief than any medication.
Classification guides management: The first step is always to determine if pain is cyclical, non-cyclical, or extramammary. This single distinction determines the entire approach to workup and treatment.
Normal examination is the norm: Most benign causes of breast pain — including cyclical mastalgia, fibrocystic changes, and medication-induced pain — present with a completely normal physical examination.
A pain diary clarifies cyclicity: When the relationship to menses is unclear, a 2-3 month daily pain diary objectively demonstrates patterns that patients may not recognize.
Always review medications: Hormonal contraceptives, hormone replacement therapy, selective serotonin reuptake inhibitors, and antipsychotics commonly cause breast pain. A medication timeline can be diagnostic.
Well-fitting bra matters: Up to 70% of women wear incorrectly fitted bras. Professional fitting and a supportive bra can significantly improve breast pain, especially in women with larger breasts.
Critical Pitfalls to Avoid
Dismissing persistent focal pain: While most breast pain is benign, persistent unilateral focal pain that does not change over 2-3 months warrants imaging, even with a normal examination.
Imaging chest wall pain: Ordering breast imaging for obvious costochondritis or musculoskeletal pain leads to unnecessary tests, incidental findings, patient anxiety, and healthcare costs.
Forgetting to examine the chest wall: Failing to perform the lean-forward test means missing the 10-15% of “breast pain” cases that are actually chest wall pain requiring different treatment.
Assuming postmenopausal women cannot have cyclical-type pain: Women on hormone replacement therapy can develop hormone-related breast pain that mimics cyclical mastalgia.
Missing inflammatory breast cancer: Diffuse breast erythema, warmth, and peau d’orange may be mistaken for mastitis. If “mastitis” does not respond to antibiotics within 1-2 weeks in a non-lactating woman, urgent imaging and biopsy are required.
Over-investigating typical cyclical mastalgia: A young woman with classic cyclical symptoms and a normal examination does not routinely need imaging. Over-investigation can cause more harm through anxiety and incidental findings.
Ignoring cardiac risk factors: Chest or breast pain in a patient with cardiac risk factors requires at least consideration of cardiac causes. Do not assume all pain in the breast region is breast-related.
Incomplete medication history: Failing to ask about herbal supplements, over-the-counter medications, and recently discontinued medications can miss drug-induced causes.
Key Takeaways
- Breast pain is extremely common (up to 70% lifetime prevalence) but is rarely associated with breast cancer (less than 1% when pain is the only symptom).
- The first and most important step is to classify the pain as cyclical mastalgia (65-70%), non-cyclical mastalgia (20-25%), or extramammary pain (10-15%).
- Cyclical mastalgia is bilateral, diffuse, worst premenstrually, and improves with menses — it is almost always benign and often responds to reassurance and lifestyle modifications.
- Non-cyclical mastalgia is typically unilateral and focal — imaging is usually indicated to evaluate for cysts, fibrosis, or other structural causes.
- Extramammary (chest wall) pain is identified by reproducible tenderness on the chest wall and a positive lean-forward test — breast imaging is not needed.
- Red flags requiring urgent evaluation include: palpable mass, skin changes (dimpling, peau d’orange), nipple changes (retraction, bloody discharge), and axillary lymphadenopathy.
- Imaging decisions are guided by age, risk factors, and clinical findings — not all breast pain requires imaging.
- Always review medications as a potential cause — hormonal therapies, antidepressants, and antipsychotics are common culprits.
- A thorough evaluation followed by clear reassurance is often the most effective treatment for breast pain.
- When in doubt, or when pain is persistent, focal, and unexplained, imaging and specialist referral are appropriate.
Quick Reference Algorithm
Systematic Approach to Breast Pain:
- Assess for red flags: Mass? Skin changes? Nipple abnormalities? Fever? → If present, urgent imaging and possible referral
- Classify the pain: Cyclical versus non-cyclical versus extramammary
- Perform the lean-forward test: If tender point stays on chest wall → treat chest wall, not breast
- Review medications: Onset correlates with new medication? → Consider drug-induced cause
- Decide on imaging: Based on age, risk factors, clinical findings, and classification
- Provide reassurance: Address cancer fears directly; explain the benign nature of most breast pain
- Initiate appropriate treatment: Lifestyle modifications for cyclical; targeted treatment for non-cyclical; chest wall treatment for extramammary
- Arrange follow-up: Reassess in 4-8 weeks; adjust management based on response